BlackRock’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
3,136,669
+306,147
| +11% | +$2.03M | ﹤0.01% | 2957 |
|
|
2025
Q1 | $25.9M | Buy |
2,830,522
+37,573
| +1% | +$344K | ﹤0.01% | 2755 |
|
|
2024
Q4 | $29.3M | Buy |
2,792,949
+120,689
| +5% | +$1.27M | ﹤0.01% | 2760 |
|
|
2024
Q3 | $31.9M | Buy |
2,672,260
+300,879
| +13% | +$3.6M | ﹤0.01% | 2706 |
|
|
2024
Q2 | $13.6M | Buy |
2,371,381
+1,838,568
| +345% | +$10.6M | ﹤0.01% | 3156 |
|
|
2024
Q1 | $2.77M | Buy |
532,813
+27,239
| +5% | +$142K | ﹤0.01% | 3829 |
|
|
2023
Q4 | $2.66M | Sell |
505,574
-1,460
| -0.3% | -$7.69K | ﹤0.01% | 3853 |
|
|
2023
Q3 | $1.67M | Buy |
507,034
+37,955
| +8% | +$125K | ﹤0.01% | 4006 |
|
|
2023
Q2 | $1.36M | Sell |
469,079
-1,472,251
| -76% | -$4.25M | ﹤0.01% | 4125 |
|
|
2023
Q1 | $2.08M | Sell |
1,941,330
-266,186
| -12% | -$285K | ﹤0.01% | 3964 |
|
|
2022
Q4 | $5.76M | Buy |
2,207,516
+56,196
| +3% | +$147K | ﹤0.01% | 3594 |
|
|
2022
Q3 | $15.1M | Buy |
2,151,320
+151,471
| +8% | +$1.06M | ﹤0.01% | 3139 |
|
|
2022
Q2 | $13.6M | Buy |
1,999,849
+216,762
| +12% | +$1.48M | ﹤0.01% | 3257 |
|
|
2022
Q1 | $25.1M | Sell |
1,783,087
-31,945
| -2% | -$450K | ﹤0.01% | 2958 |
|
|
2021
Q4 | $26.3M | Buy |
1,815,032
+1,081,692
| +148% | +$15.7M | ﹤0.01% | 3055 |
|
|
2021
Q3 | $10.4M | Buy |
733,340
+293,206
| +67% | +$4.15M | ﹤0.01% | 3599 |
|
|
2021
Q2 | $7.75M | Buy |
440,134
+48,308
| +12% | +$850K | ﹤0.01% | 3673 |
|
|
2021
Q1 | $5.99M | Buy |
+391,826
| New | +$5.99M | ﹤0.01% | 3795 |
|